ROBIN C. KRAMER - Corporate Board Profile

Armata Pharmaceuticals, Inc.

Filing Date	Source Excerpt
2020-10-22	Robin C. Kramer will serve as a member of the Audit Committee if she is elected as a director at the meeting. ... No compensation details were provided for Ms. Kramer in the filing.
2021-02-26	The special committee of the Board comprised of Todd R. Patrick, Joseph M. Patti and Robin C. Kramer, determined that the Purchase Agreement and the transactions contemplated thereby, including the Private Placement, are expedient and in the best interests of the Company and its shareholders.
2021-04-21	Robin C. Kramer has served as Senior Vice President, Chief Accounting Officer and Head of Global Business Services and Treasury of Biogen, a biopharma company, since January 2021. ... Ms. Kramer was selected as a director because of her years of experience in biotechnology and life sciences research and development and her in-depth knowledge of the industry. She has financial expertise, including a thorough understanding of financial statements, corporate finance and accounting and extensive experience with public companies, all of which makes her a valued member of the board of directors.
2022-03-09	Robin C. Kramer (Director)(4) Consists of 15,000 shares of Common Stock that Ms. Kramer has the right to acquire from us within 60 days of January 31, 2022, pursuant to the exercise of stock options.
2022-10-17	Robin C. Kramer has served as Senior Vice President, Chief Accounting Officer and Head of Global Business Services and Treasury of Biogen, a biopharma company, since January 2021. Ms. Kramer served as Biogen’s Vice President, Chief Accounting Officer from November 2018 to December 2020. Prior to joining Biogen, Ms. Kramer served as the Senior Vice President and Chief Accounting Officer of Hertz Global Holdings, Inc., a car rental company, from May 2014 to November 2018. Prior to that, Ms. Kramer was an audit partner at Deloitte & Touche LLP (Deloitte), a professional services firm, from 2007 to 2014, including serving in Deloitte’s National Office Accounting Standards and Communications Group from 2007 to 2010. From 2005 to 2007 Ms. Kramer served as Chief Accounting Officer of Fisher Scientific International, Inc., a laboratory supply and biotechnology company, and from 2004 to 2005 Ms. Kramer served as Director, External Reporting, Accounting and Control for the Gillette Company, a personal care company. Ms. Kramer also held partner positions in the public accounting firms of Ernst & Young LLP and Arthur Andersen LLP. Ms. Kramer is a licensed certified public accountant (CPA) in Massachusetts. She is a member of the Massachusetts Society of CPAs and the American Institute of CPAs. She has served as a Board member of the Center for Women and Enterprise from August 2020 – Present. She previously served as a Board Member of Samsung Bioepis Co., LTD. from July 2020 to April 2022, the Massachusetts State Board of Accountancy from September 2011 to December 2015 and Probus Insurance Company Europe DAC, from 2016 to 2018.
2023-08-03	Robin C. Kramer was elected as the Company’s Chair of the Board in March 2023 and has served as a member of the board of directors since December 2020. Ms. Kramer has served as Senior Vice President, Chief Accounting Officer and Head of Global Business Services and Treasury of Biogen, a biopharma company, since January 2021.
2024-04-29	Robin C. Kramer was elected as the Company’s Chair of the Board in March 2023 and has served as a member of the board of directors since December 2020. Ms. Kramer has served as Senior Vice President, Chief Accounting Officer and Head of Global Business Services and Treasury of Biogen, a biopharma company, since January 2021.